Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac N.V (CVAC) FCF Margin: 2020-2025

Historic FCF Margin for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -3,378.47%.

  • CureVac N.V's FCF Margin fell 276118.00% to -3,378.47% in Q2 2025 from the same period last year, while for Jun 2025 it was 40.45%, marking a year-over-year increase of 48077.00%. This contributed to the annual value of 16.36% for FY2024, which is 61200.00% up from last year.
  • Latest data reveals that CureVac N.V reported FCF Margin of -3,378.47% as of Q2 2025, which was up 27.08% from -4,633.15% recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's FCF Margin ranged from a high of 1,333,310.37% in Q4 2021 and a low of -1,226,345.96% during Q2 2021.
  • Over the past 3 years, CureVac N.V's median FCF Margin value was -698.83% (recorded in 2024), while the average stood at -1,260.00%.
  • Examining YoY changes over the last 5 years, CureVac N.V's FCF Margin showed a top increase of 190,295,584bps in 2022 and a maximum decrease of 133,372,991bps in 2022.
  • CureVac N.V's FCF Margin (Quarterly) stood at 1,333,310.37% in 2021, then plummeted by 133,372,991bps to -419.54% in 2022, then skyrocketed by 22,660bps to -192.94% in 2023, then slumped by 26,611bps to -459.05% in 2024, then tumbled by 276,118bps to -3,378.47% in 2025.
  • Its FCF Margin stands at -3,378.47% for Q2 2025, versus -4,633.15% for Q1 2025 and -459.05% for Q4 2024.